We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Activated Brown Fat Controls Obesity and Metabolic Disorders

By LabMedica International staff writers
Posted on 08 May 2013
Researchers speculate that the development of new drugs to activate human brown adipose tissue (BAT) could lead to safe treatments for obesity and metabolic disorders.

White adipose tissue (WAT) stores excess calories, while BAT consumes molecular fuel for thermogenesis (heat generation) using the tissue-specific enzyme UCP1(uncoupling protein 1).

Image: First author Dr. Aaron Cypess is an assistant professor of medicine at Harvard Medical School (Photo courtesy of Joslin Diabetes Center, Beth Deaconess Medical Center, Harvard University Medical School).
Image: First author Dr. Aaron Cypess is an assistant professor of medicine at Harvard Medical School (Photo courtesy of Joslin Diabetes Center, Beth Deaconess Medical Center, Harvard University Medical School).

Investigators at Harvard Medical School (Boston, MA, USA) delved into the genetic expression and protein activities found in BAT to determine its possible future role in the treatment of obesity. To this end, they isolated neck fat from adult human volunteers and compared its gene expression, differentiation capacity, basal oxygen consumption, and oxygen consumption rate (OCR), to different mouse adipose depots.

Among findings reported in the April 21, 2013, online edition of the journal Nature Medicine was that the OCR of the human BAT cells from the deep location in the neck next to the longus colli was nearly 50% of the rate found for mouse BAT cells. In contrast, the OCR of human WAT was only one-hundredth of the OCR found in the most active human BAT from the longus colli depot.

The investigators established a protocol for growth in culture of new functional BAT cells (adipocytes) by differentiating precursor cells (preadipocytes) derived from both superficial and deep human neck fat tissue. When stimulated, these cells expressed the same genes as naturally occurring brown fat cells. The use of brown fat cells produced in vitro will encourage development of drugs and other treatments that increase BAT activity for the correction of obesity and other metabolic disorders.

“BAT is most abundant in the deep locations of the neck, close to the sympathetic chain and the carotid arteries, where it likely helps to warm blood and raise body temperature,” said first author Dr. Aaron M. Cypess, assistant professor of medicine at Harvard Medical School. “Now that we know where brown fat is, we can easily collect more cells for further study.”

“Our research has significant practical applications. If we stimulate the growth of brown fat in people, it may burn their white fat and help them lose weight, which lessens insulin resistance and improves diabetes,” said Dr. Cypess.

Related Links:

Harvard Medical School



Gold Member
Turnkey Packaging Solution
HLX
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Sulfidoleukotrienes (sLT) Assay
CAST ELISA
New
CVD Risk Test
GammaCoeur CVD Risk ELISA Test

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries